Open access
4,527
Views
44
CrossRef citations to date
0
Altmetric
Report
Glycosylation profile and biological activity of Remicade® compared with Flixabi® and Remsima®
Changsoo LeeQuality Evaluation Team, Samsung Bioepis Co., Ltd., Incheon, Republic of KoreaCorrespondence[email protected]
, Min JeongQuality Evaluation Team, Samsung Bioepis Co., Ltd., Incheon, Republic of Korea
http://orcid.org/0000-0002-2424-6481
JongAh Joanne LeeQuality Evaluation Team, Samsung Bioepis Co., Ltd., Incheon, Republic of Korea
, Saebom SeoQuality Evaluation Team, Samsung Bioepis Co., Ltd., Incheon, Republic of Korea
, Sung Chun ChoQuality Evaluation Team, Samsung Bioepis Co., Ltd., Incheon, Republic of Korea
, Wei ZhangDepartment of Analytical Development, Biogen, Inc., Cambridge, MA, USA
& Orlando JaquezDepartment of Medical Affairs, Biosimilars, Biogen, Zug, Switzerland
http://orcid.org/0000-0002-2885-5081
Pages 968-977
|
Received 13 Apr 2017, Accepted 26 May 2017, Published online: 12 Jul 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.